Cargando…
Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126497/ https://www.ncbi.nlm.nih.gov/pubmed/35605093 http://dx.doi.org/10.1002/ctm2.879 |
_version_ | 1784712143741911040 |
---|---|
author | Yin, Lin Li, Na Jia, Weihua Wang, Nuoqi Liang, Meidai Shang, Jiamin Qiang, Guifen Du, Guanhua Yang, Xiuying |
author_facet | Yin, Lin Li, Na Jia, Weihua Wang, Nuoqi Liang, Meidai Shang, Jiamin Qiang, Guifen Du, Guanhua Yang, Xiuying |
author_sort | Yin, Lin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9126497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91264972022-05-25 Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy Yin, Lin Li, Na Jia, Weihua Wang, Nuoqi Liang, Meidai Shang, Jiamin Qiang, Guifen Du, Guanhua Yang, Xiuying Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-05-23 /pmc/articles/PMC9126497/ /pubmed/35605093 http://dx.doi.org/10.1002/ctm2.879 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Yin, Lin Li, Na Jia, Weihua Wang, Nuoqi Liang, Meidai Shang, Jiamin Qiang, Guifen Du, Guanhua Yang, Xiuying Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
title | Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
title_full | Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
title_fullStr | Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
title_full_unstemmed | Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
title_short | Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
title_sort | antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126497/ https://www.ncbi.nlm.nih.gov/pubmed/35605093 http://dx.doi.org/10.1002/ctm2.879 |
work_keys_str_mv | AT yinlin antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT lina antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT jiaweihua antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT wangnuoqi antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT liangmeidai antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT shangjiamin antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT qiangguifen antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT duguanhua antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy AT yangxiuying antagonizingurotensinreceptorisanoveltherapeuticstrategyforglucocorticoidinducedskeletalmuscleatrophy |